Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians

被引：9

作者：

Cocchetti, Carlotta ^{[1
]}

Ristori, Jiska ^{[1
]}

Mazzoli, Francesca ^{[1
]}

Vignozzi, Linda ^{[1
]}

Maggi, Mario ^{[2
]}

Fisher, Alessandra Daphne ^{[1
]}

机构：

[1] Florence Univ Hosp, Androl Womens Endocrinol & Gender Incongruence Un, Viale Pieraccini 6, I-50139 Florence, Italy

[2] Careggi Univ Hosp, Dept Expt Clin & Biomed Sci, Viale Pieraccini 6, I-50139 Florence, Italy

来源：

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | 2021年 / 33卷 / 07期

关键词：

SURGICALLY MENOPAUSAL WOMEN; INTRAVAGINAL DEHYDROEPIANDROSTERONE DHEA; VULVO-VAGINAL ATROPHY; TESTOSTERONE PATCH; POSTMENOPAUSAL WOMEN; GENITOURINARY SYNDROME; SEVERE DYSPAREUNIA; TRANSSEXUAL WOMEN; GENDER DYSPHORIA; EFFICACY;

D O I：

10.1038/s41443-021-00409-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Hypoactive sexual desire disorder (HSDD) represents a common condition among transgender women. However, to date no specific guidelines for the management of HSDD in transgender persons are available. The aim of the present narrative Review is to evaluate evidence-based treatment for HSDD and to suggest treatment options for HSDD in transgender women. Clinically relevant publications on the management of HSDD (from 1985 to 2020) were searched in PubMed and Medline databases, using the following terms: "sexual desire", "sexual health", "HSDD", "transgender", "gender-affirming treatment", "sexual therapy", "testosterone treatment", "Central nervous system-active medications", and variants. Since sexual desire could be affected by several factors, a comprehensive assessment of HSDD- exploring biological, psychological, and social domains- is recommended, in order to identify possible predisposing, precipitating and maintaining factors. Among treatment options, transgender women may benefit of different sex therapy strategies and/or central nervous system-active medications-such as flibanserin, bremelanotide, bupropion and buspirone-and transdermal testosterone, bearing in mind that this option could be poorly accepted by patients due to the risk of virilizing effects. The lack of data regarding the efficacy of HSDD treatment options in transgender women emphasize the need for literature to focus more on this topic in the future.

引用

页码：703 / 709

页数：7

共 72 条

[51] Testosterone treatment of HSDD in naturally menopausal women: the ADORE study [J].

Panay, N. ;

Al-Azzawi, F. ;

Bouchard, C. ;

Davis, S. R. ;

Eden, J. ;

Lodhi, I. ;

Rees, M. ;

Rodenberg, C. A. ;

Rymer, J. ;

Schwenkhagen, A. ;

Sturdee, D. W. .

CLIMACTERIC, 2010, 13 (02) :121-131

[52] Toward Personalized Sexual Medicine (Part 2): Testosterone Combined with a PDE5 Inhibitor Increases Sexual Satisfaction in Women with HSDD and FSAD, and a Low Sensitive System for Sexual Cues [J].

Poels, Saskia ;

Bloemers, Jos ;

van Rooij, Kim ;

Goldstein, Irwin ;

Gerritsen, Jeroen ;

van Ham, Diana ;

van Mameren, Frederiek ;

Chivers, Meredith ;

Everaerd, Walter ;

Koppeschaar, Hans ;

Olivier, Berend ;

Tuiten, Adriaan .

JOURNAL OF SEXUAL MEDICINE, 2013, 10 (03) :810-823

[53] Hormonal Treatment Effect on Sexual Distress in Transgender Persons: 2-Year Follow-Up Data [J].

Ristori, Jiska ;

Cocchetti, Carlotta ;

Castellini, Giovanni ;

Pierdominici, Marina ;

Cipriani, Agnese ;

Testi, Diletta ;

Gavazzi, Gioele ;

Mazzoli, Francesca ;

Mosconi, Maddalena ;

Meriggiola, Maria Cristina ;

Cassioli, Emanuele ;

Vignozzi, Linda ;

Ricca, Valdo ;

Maggi, Mario ;

Fisher, Alessandra D. .

JOURNAL OF SEXUAL MEDICINE, 2020, 17 (01) :142-151

[54] Correlates of Sexually Related Personal Distress in Women with Low Sexual Desire [J].

Rosen, Raymond C. ;

Shifren, Jan L. ;

Monz, Brigitta U. ;

Odom, Dawn M. ;

Russo, Patricia A. ;

Johannes, Catherine B. .

JOURNAL OF SEXUAL MEDICINE, 2009, 6 (06) :1549-1560

[55] A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women [J].

Safarinejad, Mohammad Reza ;

Hosseini, Seyyed Yousof ;

Asgari, Majid Ali ;

Dadkhah, Farid ;

Taghva, Arsia .

BJU INTERNATIONAL, 2010, 106 (06) :832-839

[56] Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women [J].

Segraves, RT ;

Clayton, A ;

Croft, H ;

Wolf, A ;

Warnock, J .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2004, 24 (03) :339-342

[57] Genital sensitivity after sex reassignment surgery in transsexual patients [J].

Selvaggi, Gennaro ;

Monstrey, Stan ;

Ceulemans, Peter ;

T'Sjoen, Guy ;

De Cuypere, Griet ;

Hoebeke, Piet .

ANNALS OF PLASTIC SURGERY, 2007, 58 (04) :427-433

[58] Treatment-Emergent Sexual Dysfunction Related to Antidepressants A Meta-Analysis [J].

Serretti, Alessandro ;

Chiesa, Alberto .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) :259-266

[59]

Shifren JL, 2006, MENOPAUSE, V13, P770, DOI 10.1097/01.gme.0000227400.60816.52

[60]

Sigurjonsson H., 2015, JPRAS Open, V6, P69, DOI [DOI 10.1016/J.JPRA.2015.09.003, 10.1016/j.jpra.2015.09.003, 10.1016/j.jpra.2015.09, DOI 10.1016/J.JPRA.2015.09]

← 1 2 3 4 5 6 7 8 →